Carmel, Indiana, July 16, 2024 LONDON, Oct 23, 2020 /PRNewswire/ — Syra Health Corp. (NASDAQ: SYRA) (“Syra Health” or the “Company”), a healthcare technology company driving better health by delivering meaningful solutions, today announced it is offering its AI developed to redact personally identifiable information pursuant to HIPAA regulations free of charge. Syra Health offers configurable solutions to the healthcare and technology community to redact personally identifiable information or expand its use in new ways.
“At Cira Health, we understand how complex HIPAA and AI can be,” Travis Somerville“So we're sharing some of our artificial intelligence,” said Syra, AI lead at Syra Health. “AI is constantly getting smarter, and the algorithms we provide contain our knowledge, run offline and privately, and can be enhanced by others to add to and extend it as needed.”
“Our AI governance is committed to the ethical, responsible and open-source use of AI,” he said. Deepika VuppalaniCEO, Shira Health“By leveraging our AI, we protect personally identifiable information while driving broader compliance with HIPAA.”
If you are interested in obtaining the Personal Information Redaction Code, please fill out this form. Syra Health will be hosting a series of webinars to explain how to utilize and collaborate with the AI Code, as well as share cybersecurity best practices to protect your organization's Personal Information data.
In the spirit of open-source collaboration, Syra Health announced the AI Giveaway as part of Artificial Intelligence Appreciation Day, a day to recognize the benefits of AI.
ABOUT SYRA HEALTH
Syra Health is a healthcare technology company delivering innovative services and technology products to drive health improvements in challenging areas such as behavioral and mental health, digital health and population health. Syra Health's services are focused on prevention, improving access and affordable care. Syra Health delivers solutions to payers, providers, life sciences organizations, academic institutions and government. For more information, visit www.syrahealth.com.
Forward-Looking Statements
Statements in this press release regarding future expectations, plans and prospects, as well as other statements regarding matters that are not historical facts, may constitute “forward-looking statements.” These statements include, but are not limited to, statements regarding the anticipated uses of proceeds, our operations and business strategy, and our expected financial results. Words such as “anticipate,” “believe,” “continue,” “may,” “estimate,” “expect,” “intend,” “may,” “plan,” “potential,” “predict,” “project,” “should,” “target,” “will,” “would” and similar expressions are intended to identify forward-looking statements, although not all forward-looking statements contain these identifying words. The forward-looking statements contained in this press release are based on management's current expectations and are subject to significant risks, uncertainties and changes in circumstances. Investors should read the risk factors set forth in our Form 10-K for the fiscal year ended December 31, 2019. December 31, 2023and our other periodic reports filed with the Securities and Exchange Commission. The forward-looking statements contained in this press release speak only as of the date hereof, and, except as required by the federal securities laws, the Company expressly disclaims any obligation to update any forward-looking statements, whether as a result of new information, future events or otherwise.
contact address
For media enquiries please contact:
Christine Drury
Communications and Marketing Director
Shira Health
463-345-5180
[email protected]
For investor inquiries, please contact:
Ben Shamshian
vice president
Ritham Partners LLC
646-829-9701
[email protected]
SOURCE Syra Health
